# EDGAR Filing Document

**Accession Number:** 0002088295
**File Stem:** 0001213900-26-071789
**Filing Date:** 2026-6
**Character Count:** 29493
**Document Hash:** b4239d0669320d5ae18e8317783abf83
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-071789.hdr.sgml**: 20260625

**ACCESSION NUMBER**: 0001213900-26-071789

**CONFORMED SUBMISSION TYPE**: 425

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260625

**DATE AS OF CHANGE**: 20260625

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bleichroeder Acquisition Corp. II
- **CENTRAL INDEX KEY:** 0002088295
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43045
- **FILM NUMBER:** 261117802

**BUSINESS ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
- **BUSINESS PHONE:** 212-984-3815

**MAIL ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bleichroeder Acquisition Corp. II
- **CENTRAL INDEX KEY:** 0002088295
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425

**BUSINESS ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
- **BUSINESS PHONE:** 212-984-3815

**MAIL ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): June 25, 2026**

**Bleichroeder Acquisition Corp. II**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-43045** | **98-1888010** |
| **(State or other jurisdiction<br> of incorporation)** | **(Commission File Number)** | **(IRS Employer <br> Identification No.)** |

---

**1345 Avenue of the Americas, Fl 47<br> New York, NY 10105**

**(Address of principal executive offices, including zip code)**

**Registrant's telephone number, including area code: 212-984-3835**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant | BBCQU | The Nasdaq Stock Market LLC |
| Class A ordinary shares, par value $0.0001 per share | BBCQ | The Nasdaq Stock Market LLC |
| Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share | BBCQW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry Into a Material Definitive Agreement**

*Amendment No. 2 to Agreement and Plan of Merger*

 

As previously announced, (i) on February 28, 2026, Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company ("**Parent**" or "**Bleichroeder**"), entered into an Agreement and Plan of Merger (the "**Agreement**") by and among Parent, Bleichroeder Acquisition 2 France, a *société par actions simplifiée* formed under the laws of the Republic of France and a wholly owned subsidiary of Parent ("**Initial Merger Sub**"), and Pasqal Holding SAS, a *société par actions simplifiée* formed under the laws of the Republic of France ("**Pasqal**"), and (ii) on May 26, 2026, Parent, Initial Merger Sub, Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France ("**Parent Merger Sub**"), and Pasqal entered into Amendment No. 1 to the Agreement and Plan of Merger and Assignment and Assumption Agreement (the "**Amendment No. 1**"). The Agreement, as amended by Amendment No. 1, and as may be further amended from time to time, is referred to herein as the "**Business Combination Agreement**." The transactions contemplated by the Business Combination Agreement are hereinafter referred to as the "**Business Combination**." Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Business Combination Agreement.

On June 25, 2026, Parent, Parent Merger Sub and Pasqal entered into Amendment No. 2 to the Agreement and Plan of Merger (the "**Amendment No. 2**"). Amendment No. 2 amends the Business Combination Agreement to revise the composition of the board of directors of the surviving corporation of the Business Combination (the "**Surviving Corporation**"), following the consummation of the Business Combination, and to revise the terms of the equity incentive plan to be adopted by the Surviving Corporation in connection with the Business Combination.

As amended, the Surviving Corporation's initial board of directors will consist of nine directors, five of whom will be French or European citizens and non-U.S. residents. Six of such directors will be designated jointly by Parent and Pasqal prior to the closing of the Business Combination (the "**Closing**") and will be mutually acceptable to Parent and Pasqal, and the remaining directors will be determined prior to the Closing in accordance with the terms of the Business Combination Agreement and will be independent directors under Nasdaq rules and applicable law.

Amendment No. 2 also amends the Business Combination Agreement to, among other things, remove the provision under which the equity incentive plan to be adopted by the Surviving Corporation in connection with the Business Combination (the "**LTIP**") would have provided for awards to the chief executive officer and the chairman of Pasqal's supervisory board in respect of a number of the Surviving Corporation's shares of up to one percent (1%) of the aggregate number of the Surviving Corporation's shares issued and outstanding immediately after the Closing on a fully-diluted and as-converted basis (after giving effect to any redemptions by Parent's shareholders), in addition to the ten percent (10%) of such shares for which the LTIP will otherwise provide.

The foregoing description of Amendment No. 2 is qualified in its entirety by reference to the full text of Amendment No. 2, a copy of which is attached as Exhibit 2.1 hereto and is incorporated herein by reference.

**Forward Looking Statements**

This communication contains certain statements that are not historical facts but may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "**Securities Act**"), and Section 21E of the Exchange Act. Forward-looking statements generally are accompanied by words such as "believe," "may," "might," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "could," "plan," "predict," "project," "forecast," "potential," "seem," "seek," "target," "possible," "future," "outlook" or the negatives of these terms or variations of them or similar terminology or expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, the proposed business combination between Bleichroeder and Pasqal, and other statements that are not historical facts.

These statements are based on the current expectations of Bleichroeder and/or Pasqal's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Bleichroeder and Pasqal. These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions regarding Pasqal's business and the business combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political, social and business conditions; uncertainty or changes with respect to laws and regulations; uncertainty or changes with respect to taxes, trade conditions and the macroeconomic environment; the inability of the parties to consummate the business combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination agreement entered into in connection to the business combination, including failure by Bleichroeder or Pasqal to receive their respective shareholder approval or required regulatory approvals of the business combination; the number of redemption requests made by Bleichroeder's shareholders in connection with the business combination, leaving the combined company with insufficient cash to execute its business plans; the outcome of any legal proceedings or governmental investigations that may be instituted against the parties following the announcement of the business combination; failure to realize the anticipated benefits of the business combination, including as a result of a delay in consummating the potential transaction; the risk that the business combination disrupts Pasqal's current plans and operations as a result of the announcement and consummation of the business combination; the risks related to Pasqal meeting expected business milestones; the effects of competition on Pasqal's business; the ability of the combined company to execute its growth strategy, manage growth profitably and retain its key employees; the ability of the combined company to obtain or maintain the listing of its securities on a U.S. national securities exchange following the business combination; the ability to achieve dual listing on Euronext N.V. Paris following the business combination; costs related to the business combination; the ability of Bleichroeder or the combined company to raise capital or issue debt, equity or equity-linked securities in connection with the proposed business combination or in the future on reasonable terms or at all; the combined company's ability to maintain internal control over financial reporting and operate as a public company; the risk from Pasqal pursuing an emerging technology, facing significant technical challenges and the potential that it may not achieve commercialization or market acceptance; Pasqal's financial performance and limited operating history; Pasqal's expectations regarding future financial performance, capital requirements and unit economics; Pasqal's use and reporting of business and operational metrics; Pasqal's competitive landscape; Pasqal's dependence on members of its senior management and its ability to attract and retain qualified personnel; Pasqal's potential need for additional future financing prior to or after the business combination as a combined company; Pasqal's concentration of revenue in contracts with government or state-funded entities; Pasqal's ability to manage growth and expand its operations; potential future acquisitions or investments in companies, products, services or technologies; Pasqal's reliance on strategic partners and other third parties; Pasqal's ability to maintain, protect and defend its intellectual property rights; risks associated with privacy, data protection or cybersecurity incidents and related regulations; the use, rate of adoption and regulation of artificial intelligence and machine learning; and other risks that will be detailed from time to time in filings with the SEC. The foregoing list of risk factors is not exhaustive. There may be additional risks that Pasqal and Bleichroeder presently do not know or that Pasqal and Bleichroeder currently believe are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide Pasqal's and/or Bleichroeder's expectations, plans and forecasts of future events and views as of the date of this communication. Pasqal and Bleichroeder anticipate that subsequent events and developments will cause their assessments to change. However, while Pasqal and/or Bleichroeder may elect to update these forward-looking statements in the future, Pasqal and Bleichroeder specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Pasqal's or Bleichroeder's assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements. Nothing herein should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or results of such forward-looking statements will be achieved.

An investment in Bleichroeder is not an investment in any of its founders' or sponsors' past investments, companies or affiliated funds. The historical results of those investments are not indicative of future performance of Bleichroeder, which may differ materially.

**Additional Information and Where to Find It**

The business combination will be submitted to shareholders of Bleichroeder for their consideration. In connection with the business combination, Bleichroeder, Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France and Pasqal have jointly filed a registration statement on Form F-4 (the "**Registration Statemen**t") with the SEC, which includes a proxy statement/prospectus and certain other related documents, which will serve as both the proxy statement/prospectus to be distributed to its shareholders in connection with its solicitation for proxies for the vote by its shareholders in connection with the business combination and other matters to be described in the Registration Statement, as well as the prospectus relating to the offer and sale of the securities to be issued to Pasqal's shareholders in connection with the completion of the business combination. After the Registration Statement is declared effective, Bleichroeder will mail a definitive proxy statement/prospectus and other relevant documents to its shareholders as of the record date established for voting on the business combination. This communication is not a substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that Bleichroeder will send to its shareholders in connection with the business combination.

BEFORE MAKING ANY INVESTMENT OR VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS AND, IN EACH CASE, ANY AMENDMENTS THERETO FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION, RELATED TRANSACTIONS AND THE PARTIES TO THE BUSINESS COMBINATION. Investors and security holders will be able to obtain copies of these documents (if and when available) and other documents filed with the SEC free of charge at www.sec.gov. The definitive proxy statement/final prospectus (if and when available) will be mailed to shareholders of Bleichroeder as of a record date to be established for voting on the business combination. Shareholders of Bleichroeder will also be able to obtain copies of the proxy statement/prospectus without charge, once available, at the SEC's website at www.sec.gov.

**Participants in the Solicitation**

Bleichroeder and its directors, executive officers, and other members of management, and consultants, under SEC rules, may be deemed participants in the solicitation of proxies from Bleichroeder's shareholders with respect to the business combination. A list of the names of those directors and executive officers and a description of their interests in Bleichroeder and the business combination is contained in the sections entitled "Directors, Executive Officers and Corporate Governance," "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters," and "Certain Relationships and Related Transactions, and Director Independence" of the Annual Report filed by Bleichroeder with the SEC on March 16, 2026 and the Current Report on Form 8-K filed with the SEC on May 1, 2026, and each of which is available free of charge at the SEC's website at www.sec.gov. Additional information regarding the interests of participants in the proxy solicitation and their direct and indirect interests will be contained in the Registration Statement and the proxy statement/prospectus when they become available.

Pasqal, its directors, executive officers, other members of management, employees and consultants, under SEC rules, may be deemed participants in the solicitation of proxies of Bleichroeder's shareholders in connection with the business combination. A list of the names of such directors and executive officers and information regarding their interests in the business combination will be included in the Registration Statement and the proxy statement/prospectus when they become available.

**No Offer or Solicitation**

This communication is for informational purposes only and is not (i) an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law nor (ii) the solicitation of any vote in any jurisdiction pursuant to the business combination or otherwise. This communication is not, and under no circumstances is to be construed as, a prospectus, an advertisement or a public offering of the securities described herein in the United States or any other jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or exemptions therefrom. No securities commission or securities regulatory authority in the United States or any other jurisdiction has in any way passed upon the merits of the business combination or the accuracy or adequacy of this communication.

**Item 9.01 Financial Statements and Exhibits**

(d) Exhibits:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 2.1 | [Amendment No. 2 to the Agreement and Plan of Merger, dated as of June 25, 2026, by and among Bleichroeder Acquisition Corp. II, Bleichroeder Acquisition France Merger Sub 2 and Pasqal Holding SAS.](ea029584201ex2-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **BLEICHROEDER ACQUISITION CORP. II** | **BLEICHROEDER ACQUISITION CORP. II** | **BLEICHROEDER ACQUISITION CORP. II** |
| Date: June 25, 2026 | By: | /s/ Marcello Padula | /s/ Marcello Padula |
|  |  | Name: | Marcello Padula |
|  |  | Title: | Chief Executive Officer and<br> Chief Operating Officer |

---

## Exhibit 2.1

**Exhibit 2.1**

**AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER**

This AMENDMENT NO. 2 to the AGREEMENT AND PLAN OF MERGER, dated as of June 25, 2026 (this "***Amendment***"), is made by and between Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company ("***Parent***"), Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France ("***Parent Merger Sub***"), and Pasqal Holding SAS, a *société par actions simplifiée* formed under the laws of the Republic of France (the "***Company***"). Parent, Parent Merger Sub and the Company shall each be referred to herein from time to time individually as a "***Party***" and collectively as the "***Parties***".

**RECITALS:**

**WHEREAS**, Parent, Parent Merger Sub and the Company are parties to that certain Agreement and Plan of Merger, dated as of February 28, 2026, as amended by Amendment No. 1 to the Agreement and Plan of Merger and Assignment and Assumption Agreement, dated as of May 26, 2026 (as may be further amended or supplemented from time to time, the "***Business Combination Agreement***");

**WHEREAS**, pursuant to Section 11.6 of the Business Combination Agreement, the Business Combination Agreement may be amended or waived prior to the Effective Time if, but only if, such amendment or waiver is in writing and executed by the Parties; and

**WHEREAS**, the Parties desire to amend the Business Combination Agreement as hereinafter set forth.

**NOW, THEREFORE** for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Definitions</u>. Capitalized
 terms used in this Amendment and not otherwise defined herein shall have the respective meanings
 ascribed to them in the Business Combination Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Amendments</u>.
 The Business Combination Agreement is hereby amended as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Section
 2.2(b) of the Business Combination Agreement is hereby deleted in its entirety and replaced
 with the following:

"<u>Closing of the Merger</u>. Unless this Agreement is earlier terminated in accordance with <u>Article X</u>, the closing of the Merger (the "<u>Closing</u>") will take place (x) at least one Business Day after the date on which the later to occur of the required approval of the shareholders of Parent Merger Sub and the Requisite Company Vote has been obtained and (y) after the Reincorporation Merger Effective Time (the "<u>Merger Approval Date</u>") by conference call and by exchange of signature pages via email or other electronic transmission, as permitted under applicable Laws, or at such other place and time as the Company and the Parent Parties may mutually agree upon (the date on which the Closing actually occurs being hereinafter referred to as the "<u>Closing Date</u>"). The Parties may participate in the Closing via electronic means.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Board of Directors of the Surviving Corporation</u>. Upon and immediately following the Merger
 Effective Time, the Surviving Corporation's initial board of directors will consist
 of nine directors, five of whom will be French or European citizens and non-US residents.
 Six of such directors shall be designated jointly by Parent and the Company prior to the
 Closing and shall be mutually acceptable to Parent and the Company. The remaining directors
 shall be determined prior to the Closing, and upon and immediately following the Effective
 Time, such remaining directors will be independent directors under Nasdaq rules and will
 be designated as follows, in accordance with the Nasdaq listing rules and applicable Law:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Bpifrance
 Investissement will have the right, but not the obligation, to designate one director representing
 BPI (that can be, if acceptable under Nasdaq rules, a BPI entity (i.e. "*personne morale*") represented by an individual);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) EIC
 Fund will have the right, but not the obligation, to designate one director; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) the
 remaining one director may be designated by either Parent or the Company and mutually agreed
 by Parent and the Company (acting upon approval of the Company's Supervisory Board).

Upon and immediately following the Merger Effective Time, the Surviving Corporation's board of directors' internal regulations will include the list of restricted matters set forth in <u>Exhibit H</u>."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Section
 2.2(b)(ii) of the Business Combination Agreement is hereby deleted in its entirety.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Section
 6.7 of the Business Combination Agreement is hereby deleted in its entirety and replaced
 with the following:

"<u>Equity Incentive Plan</u>. Effective as of (and contingent on) the Closing, the Surviving Corporation will adopt a new equity incentive plan in a form and substance reasonably acceptable to Parent and the Company and which will be approved by the Surviving Corporation's board of directors (the "<u>LTIP</u>"), and which LTIP will provide for awards for a number of Surviving Corporation Shares (in the form of founder's warrants – BSPCEs – or free shares – *actions gratuites* - up to ten percent (10%) of the aggregate number of Surviving Corporation Shares issued and outstanding immediately after the Closing on a fully-diluted and as-converted basis (after giving effect to the Parent Shareholder Redemptions, if any) (the "<u>LTIP Share Reserve</u>"). Parent and the Company will negotiate further edits to the LTIP (including vesting criteria for new award recipients based on performance conditions) in good faith based on recommendations from the Company's compensation consultant, which will be incorporated into the LTIP, subject to the approval of the Surviving Corporation's board of directors, in advance of the Parent Extraordinary General Meeting."

&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Effect of this Amendment</u>. Except as expressly provided by this Amendment, each of the provisions
 of the Business Combination Agreement shall remain unchanged and in full force and effect
 following the execution of this Amendment. Following the execution of this Amendment, references
 in the Business Combination Agreement to "this Agreement", "herein",
 "hereof" or phrases having a similar meaning shall refer to the Business Combination
 Agreement as amended by this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Entire Agreement</u>. This Amendment and the Business Combination Agreement constitute the entire
 agreement among the Parties with respect to the subject matter hereof and supersedes all
 other prior agreements and understandings, both written and oral, among the Parties or any
 of their respective Subsidiaries with respect to the subject matter hereof.

&nbsp;&nbsp;&nbsp;&nbsp;5. <u>General Provisions</u>. Section 11.3 (*Notices*), Section 11.5 (*Severability*), Section
 11.10 (*Counterparts*), and Section 11.9 (*Governing Law; Dispute Resolution Provisions*)
 of the Business Combination Agreement are incorporated herein by reference and shall apply, *mutatis mutandis*, to this Amendment as though fully set forth herein.

*[Signature pages follow]*

IN WITNESS WHEREOF, the Parties hereto have caused this Amendment to be executed by their respective authorized representatives as of the date first written above.

---

| | | |
|:---|:---|:---|
| **Bleichroeder Acquisition Corp. II** | **Bleichroeder Acquisition Corp. II** | **Bleichroeder Acquisition Corp. II** |
| By: | /s/ Marcello Padula | /s/ Marcello Padula |
|  | Name: | Marcello Padula |
|  | Title: | Chief Executive Officer |

---

---

| | | |
|:---|:---|:---|
| **BLEICHROEDER ACQUISITION FRANCE MERGER SUB 2** | **BLEICHROEDER ACQUISITION FRANCE MERGER SUB 2** | **BLEICHROEDER ACQUISITION FRANCE MERGER SUB 2** |
| By: | */s/ Michel Combes* | */s/ Michel Combes* |
|  | Name: | Michel Combes |
|  | Title: | President |

---

---

| | | |
|:---|:---|:---|
| **PASQAL HOLDING SAS** | **PASQAL HOLDING SAS** | **PASQAL HOLDING SAS** |
| By: | /s/ Wasiq Bokhari | /s/ Wasiq Bokhari |
|  | Name: | Wasiq Bokhari |
|  | Title: | President |

---